Health Canada drug identification number

DIN 02478374 — ERLEADA 60 MG

ERLEADA is a tablet of Apalutamide marketed by JANSSEN INC. The full Apalutamide monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.

DIN
02478374
Brand name
ERLEADA
Active ingredient
Apalutamide
Strength
60 MG
Dosage form
TABLET
Route
ORAL
Manufacturer
JANSSEN INC
Health Canada status
MARKETED
Drug class
Androgen receptor inhibitor (anti-androgen)

Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.

Other Apalutamide products

DINBrandStrengthFormManufacturerStatus
02540185 ERLEADA 240 MG TABLET JANSSEN INC MARKETED

Rejoining the server...

Rejoin failed... trying again in seconds.

Failed to rejoin.
Please retry or reload the page.

The session has been paused by the server.

Failed to resume the session.
Please retry or reload the page.